Intensity Therapeutics In... (INTS)
NASDAQ: INTS
· Real-Time Price · USD
0.33
-0.25 (-43.01%)
At close: Jun 12, 2025, 3:59 PM
Intensity Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -15.01M | -16.27M | -16.26M | -15.07M | -13.8M | -10.54M | -8.88M | -8.32M | -6.55M | -7.58M | -8.47M | -8.82M | -8.79M | -7.9M | -7.13M | -5M | -3.11M |
Depreciation & Amortization | -6K | n/a | 5.89K | 19.91K | 52.53K | 147K | 186.54K | 229.5K | 235.41K | 179.04K | 133.6K | 88.63K | 44.09K | 42.4K | 42.4K | 42.4K | 42.4K |
Stock-Based Compensation | 2.35M | 3.07M | 2.65M | 2.52M | 2.24M | 1.4M | 1.6M | 1.29M | 1.2M | 1.17M | 797.02K | 1.01M | 892.64K | 719.82K | 581.99K | 323.45K | 222.14K |
Other Working Capital | 1.52M | 2.04M | 1.62M | -1.81M | -1.34M | -2.15M | -2.68M | -538.68K | -156.57K | 326.02K | 285.56K | 207.86K | 277.41K | 227K | 659.84K | 407K | -65.6K |
Other Non-Cash Items | -1.79M | 824K | -515.25K | 1.03M | 3.47M | 870.67K | 2.36M | 2.51M | 148.22K | 179.04K | 177.26K | 175.52K | 173.8K | 172.11K | 170.45K | 127.22K | 84.4K |
Deferred Income Tax | n/a | n/a | 1.44M | 1.44M | 1.44M | 1.44M | -47.45K | -90.41K | -134.94K | -179.04K | -133.6K | -88.63K | -44.09K | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.12M | -2.05M | -21.55K | -1.96M | -1.46M | -522.06K | -3.11M | 579.79K | 202.97K | 756.69K | 786.77K | 448.08K | 612.14K | 176.8K | 699.52K | 374.71K | -115.86K |
Operating Cash Flow | -12.84M | -15.22M | -13.5M | -14.65M | -10.67M | -7.21M | -7.89M | -3.8M | -4.89M | -5.48M | -6.71M | -7.18M | -7.11M | -6.83M | -5.68M | -4.18M | -2.92M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -3.06M | -3.06M | -9.26M | -15.05M | -15.05M | -15.05M | -8.84M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 809.00 | 809.00 | 809.00 |
Sales Maturities Of Investments | -3.26M | n/a | 18.44M | 15.34M | 12.29M | 9.03M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.9M | 7.9M | 7.9M |
Other Investing Acitivies | n/a | 3.26M | 12.29M | 9.23M | 12.29M | 9.03M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -6.32M | -3.06M | 9.18M | -2.77M | -2.76M | -6.02M | -8.84M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.9M | 7.9M | 7.9M |
Debt Repayment | n/a | n/a | -12.55K | -12.55K | 25.45K | 230.45K | 2.49M | 2.49M | 2.46M | 2.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | -1.32M | -1.32M | -1.32M | -1.32M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 220K | -100K | 1.75M | 1.34M | 1.33M | 1.32M | -492 | -492 | 13.8K | n/a | n/a | 2.05M | 2.04M | 2.05M | 2.05M | n/a | n/a |
Financial Cash Flow | 3.22M | 2.9M | 411.84K | 20.52M | 20.27M | 20.47M | 22.73M | 2.21M | 2.47M | 2.25M | n/a | 2.05M | 2.04M | 2.05M | 2.05M | n/a | n/a |
Net Cash Flow | -6.53M | -5.97M | -3.91M | 3.11M | 6.84M | 7.24M | 6M | -1.59M | -2.43M | -3.23M | -6.71M | -5.13M | -5.07M | -4.78M | 4.27M | 3.72M | 4.98M |
Free Cash Flow | -12.84M | -15.22M | -13.5M | -14.65M | -10.67M | -7.21M | -7.89M | -3.8M | -4.89M | -5.48M | -6.71M | -7.18M | -7.11M | -6.83M | -5.68M | -4.18M | -2.92M |